26171 Tirzepatide for Sale
SS-31 MS TB CND SK SMO | US Warehouse | Cosmetic Peptides | 99% Purity | 10mg 50mg Vials | Lyophilized Powder
-
Price:
$5-5.79/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10mg/10vials/box
Retatrutide,Tirzepatide,GLOW,KLOW80,NAD+,TB500,MOTS-C
SS-31 BPC TB CND NAD | US Warehouse | Cosmetic Peptides | 99% Purity | 10mg 50mg Vials | Lyophilized Powder
-
Price:
$4-5/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10mg/10vials/box
Retatrutide,Tirzepatide,GLOW,KLOW80,NAD+,TB500,MOTS-C
SS-31 SM MS RT GHK | US Warehouse | Cosmetic Peptides | 99% Purity | 10mg 50mg Vials | Lyophilized Powder
-
Price:
$5-6/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10mg/10vials/box
Retatrutide,Tirzepatide,GLOW,KLOW80,NAD+,TB500,MOTS-C
SS-31 SM MS RT TR | US Warehouse | Cosmetic Peptides | 99% Purity | 10mg 50mg Vials | Lyophilized Powder
-
Price:
$5-5.79/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10mg/10vials/box
Retatrutide,Tirzepatide,GLOW,KLOW80,NAD+,TB500,MOTS-C
Semaglutide,Tirzepatide SM MS DS SS-31 | US Warehouse | Cosmetic Peptides | 99% Purity | 10mg 50mg Vials | Lyophilized Powder
-
Price:
$3.59-4/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10mg/10vials/box
Retatrutide,Tirzepatide,GLOW,KLOW80,NAD+,TB500,MOTS-C
Products You May Be Interested in
SS-31 KPV SM MS SMO TB | US Warehouse | Cosmetic Peptides | 99% Purity | 10mg 50mg Vials | Lyophilized Powder
-
Price:
$4-5/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10mg/10vials/box
Retatrutide,Tirzepatide,GLOW,KLOW80,NAD+,TB500,MOTS-C
SS-31 SM MS CND NAD | US Warehouse | Cosmetic Peptides | 99% Purity | 10mg 50mg Vials | Lyophilized Powder
-
Price:
$4-5/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10mg/10vials/box
Retatrutide,Tirzepatide,GLOW,KLOW80,NAD+,TB500,MOTS-C
SS-31 SM MS DS TR| US Warehouse | Cosmetic Peptides | 99% Purity | 10mg 50mg Vials | Lyophilized Powder
-
Price:
$3.5-4/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10mg/10vials/box
Retatrutide,Tirzepatide,GLOW,KLOW80,NAD+,TB500,MOTS-C
SS-31 SM LL37 TB NAD CND | US Warehouse | Cosmetic Peptides | 99% Purity | 10mg 50mg Vials | Lyophilized Powder
-
Price:
$5-6/BOU FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10mg/10vials/box
Retatrutide,Tirzepatide,GLOW,KLOW80,NAD+,TB500,MOTS-C
SS-31 SK KPV VIP OV RT | US Warehouse | Cosmetic Peptides | 99% Purity | 10mg 50mg Vials | Lyophilized Powder
-
Price:
$5-6/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10mg/10vials/box
Retatrutide,Tirzepatide,GLOW,KLOW80,NAD+,TB500,MOTS-C
- If you want to buy Tirzepatide, then ECHEMI will offer you multi-options. ECHEMI emphasizes on verifying suppliers of Tirzepatide who have registered on the platform to ensure the accuracy and reliability of suppliers. Safe transaction of chemical will be made based on true information. Buy Tirzepatide with 70000+ customers on ECHEMI and make orders now.
- Tirzepatide 2023788-19-2 from ECHEMI are quality guaranteed. Our business partners are with certification, quanlification and so on. Tirzepatide will reach global regulation and requirement of various regions. Customized services of Tirzepatide will provided to customers on ECHEMI.
- We offer reasonable and fair market price of Tirzepatide to provide better products and services. Services of Tirzepatide like trade data and market price and insight can be subscribed on ECHEMI. Efficient order options is the key for supply chain services we offer for you. Buyers are getting help to grow their business internationally on buying Tirzepatide.
- •China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
- •Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
- •Novo Nordisk’s Semaglutide Faces Strong Competition: Eli Lilly’s Tirzepatide Officially Launched in China
- •Eli Lilly Revenue Reaches $31.5 Billion, Up 27%! Tirzepatide and Semaglutide Exceed $20 Billion
- •Novo Nordisk's 2024 Earnings Surge by 23%! Diabetes Drug Sales Skyrocket, but Facing Competition Pressure from Tirzepatide
-
QIngdao Sigma Chemical Co.,Ltd
-
Dongguan Chenguang Technology Co., Ltd.
-
BrightGene Health Technology Co., Ltd
-
Synpeptide Co., Ltd
-
Maintain Biotech Co.Ltd
-
NANJING HANXIN PHARMACEUTICAL TECHNOLOGY
-
Hangzhou Go Top Peptide Biotech Co.,Ltd.
-
Deepharma Peptides/supplement
-
Xiamen Top Health Biochem Tech. Co.,Ltd
-
First Rays Co.,Ltd